Detection of gustatory and olfactory disorders as a screening criterion for the identification of patients in the early stages of COVID-19 reinfection

Autores/as

DOI:

https://doi.org/10.5935/2525-5711.20210004

Palabras clave:

COVID-19, Sensation disorders, Neurologic manifestations, Oral health

Resumen

Introduction: Variants of SARS-COV-2 have been detected and presented new capacities of infection and transmissibility, compromising the pandemic trajectory. Furthermore, chemosensory dysfunction are common symptoms of COVID-19. Objective: We aimed to provide a brief information of the current knowledge regarding chemosensory manifestations are common symptoms of COVID-19. Material and Methods: Due to the possibility of a higher incidence of the new covid-19 variants, we evaluated some studies published in the literature considering the analysis of smell and taste disorders as a criteria for the early diagnosis of positive patients and their immediate isolation. Results: Considering the economic limitations of many countries for the acquisition of results promptly by RT-PCR and immunization coverage, the evaluation of olfactory and gustatory disorders during COVID-19 outbreak can be useful tool to guide immediate isolation of the patient until the result of the laboratory test, contributing for the prevention of the virus spreading. Conclusion: As gustatory disorders are strong predictors of infection by COVID-19, health professionals should be alert for these symptoms having an important role as a screening criterion and early diagnosis.

Biografía del autor/a

Natalia Cristina Trentin-Bordignon, Federal University of Santa Catarina

Federal University of Santa Catarina, Department of Pathology - Florianópolis - Santa Catarina - Brasil

Rogério Gondak, Federal University of Santa Catarina

Federal University of Santa Catarina, Department of Pathology - Florianópolis - Santa Catarina - Brasil

Citas

Santos JA, Normando AGC, Silva RLC, Acevedo AC, Canto GL, Sugaya N, et al. Oral manifestations in patients with COVID-19: a living systematic review. J Dent Res. 2020 Sep;100(2):141-54. DOI: https://doi.org/10.1177/0022034520957289

Galloway SE, Paul P, MacCannell DR, Johansson MA, Brooks JT, MacNeil A, et al. Emergence of SARS-CoV-2 B.1.1.7 lineage - United States, December 29, 2020-January 12, 2021. Morb Mortal Wkly Rep. 2021 Jan;70(3):95-9. DOI: http://dx.doi.org/10.15585/mmwr.mm7003e2

Qiu C, Cui C, Hautefort C, Haehner A, Zhao J, Yao Q, et al. Olfactory and gustatory dysfunction as an early identifier of COVID-19 in adults and children: an international multicenter study. Otolaryngol Head Neck Surg. 2020 Jun;163(4):714-21. DOI: https://doi.org/10.1177/0194599820934376

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020 Apr;77(6):683-90. DOI: https://doi.org/10.1001/jamaneurol.2020.1127

Vaira LA, Salzano G, Deiana G, Riu G. Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope. 2020 Apr;130(7):1787. DOI: https://doi.org/10.1002/lary.28692

Descargas

Publicado

2021-01-08

Cómo citar

1.
Trentin-Bordignon NC, Gondak R. Detection of gustatory and olfactory disorders as a screening criterion for the identification of patients in the early stages of COVID-19 reinfection. J Oral Diagn [Internet]. 8 de enero de 2021 [citado 21 de septiembre de 2024];6:1-2. Disponible en: https://jordi.com.br/revista/article/view/51

Número

Sección

Letters to the Editor